UP!
| Period | Date | Adjusted Actuals EPS | GAAP EPS |
|---|---|---|---|
| Q1 2021 | 2021-05-03 | Future report Set alerts | |
| Q4 2020 | 2021-02-25 | -0.05 | -0.05 |
| Q3 2020 | 2020-10-28 | -0.05 | -0.05 |
| Q2 2020 | 2020-08-04 | -0.07 | -0.07 |
| Q1 2020 | 2020-05-04 | -0.12 | -0.12 |
| Q4 2019 | 2020-03-02 | -0.17 | -0.17 |
| Q3 2019 | 2019-11-06 | -0.20 | -0.20 |
| Q2 2019 | 2019-08-05 | -0.23 | -0.23 |
| Q1 2019 | 2019-04-30 | -0.21 | -0.21 |
| Q4 2018 | 2019-02-21 | -0.21 | -0.21 |
| 2016-06-17 | Initiated Coverage | Needham & Company LLC | Buy | $11.00 to $13.00 |
| 2016-06-08 | Reiterated Rating | Canaccord Genuity | Buy | |
| 2016-05-04 | Reiterated Rating | Canaccord Genuity | Buy | $8.00 |
| 2016-05-04 | Reiterated Rating | Needham & Company LLC | Buy | |
| 2016-02-26 | Lower Price Target | Raymond James | Outperform | $9.00 to $7.25 |
| 2016-02-26 | Lower Price Target | Cowen and Company | $7.25 to $6.50 | |
| 2016-02-26 | Lower Price Target | Raymond James Financial Inc. | Outperform | $9.00 to $7.25 |
| 2016-02-24 | Reiterated Rating | Needham & Company LLC | Buy | $13.00 to $11.00 |
| 2016-02-24 | Reiterated Rating | Canaccord Genuity | Buy | $8.00 |
| 2016-02-24 | Reiterated Rating | BTIG Research | Buy | $9.00 |
| 2016-02-24 | Lower Price Target | JPMorgan Chase & Co. | Overweight | $15.00 to $10.00 |
| 2016-02-10 | Reiterated Rating | BTIG Research | Buy | $10.00 to $9.00 |
| 2015-11-05 | Reiterated Rating | BTIG Research | Buy | $10.00 |
| 2015-10-28 | Reiterated Rating | Canaccord Genuity | Buy | $8.00 |
| 2015-10-28 | Downgrade | Cowen and Company | Outperform to Market Perform | |
| 2015-10-28 | Lower Price Target | Needham & Company LLC | Buy | $16.00 to $13.00 |
| 2015-10-14 | Lower Price Target | Cowen and Company | Outperform | $15.00 to $11.00 |
| 2015-08-10 | Reiterated Rating | Canaccord Genuity | Buy | $14.00 |
| 2015-08-10 | Reiterated Rating | BTIG Research | Buy | $15.00 |
| 2015-05-23 | Reiterated Rating | Canaccord Genuity | Buy | $14.00 |
| 2015-05-06 | Reiterated Rating | BTIG Research | Buy | $15.00 |
| 2015-05-06 | Lower Price Target | Canaccord Genuity | Buy | $16.00 to $14.00 |
| 2015-04-19 | Reiterated Rating | BTIG Research | Buy | $21.00 |
| 2015-04-17 | Lower Price Target | Canaccord Genuity | In-Line to Buy | $17.00 to $16.00 |
| 2015-04-06 | Set Price Target | Needham & Company LLC | Buy | $16.00 |
| 2015-02-25 | Set Price Target | Needham & Company LLC | Buy | $16.00 |
| 2015-02-25 | Reiterated Rating | BTIG Research | Buy | $21.00 |
| 2015-02-25 | Set Price Target | Canaccord Genuity | Buy | $17.00 |
| 2014-12-03 | Upgrade | BTIG Research | Buy | |
| 2014-08-12 | Reiterated Rating | Raymond James | Outperform | $11.00 to $13.00 |
| 2014-05-07 | Reiterated Rating | Raymond James | Outperform | $14.00 to $11.00 |
| 2014-05-07 | Reiterated Rating | JPMorgan Chase & Co. | Overweight | $17.00 to $16.00 |
| 2014-05-07 | Reiterated Rating | Cowen and Company | Outperform | $16.00 to $15.00 |
| 2014-01-24 | Boost Price Target | Canaccord Genuity | $14.00 to $17.00 | |
| 2013-12-19 | Initiated Coverage | Needham & Company LLC | Buy to Buy | $17.00 |
| 2013-11-13 | Lower Price Target | Raymond James | Outperform | $15.00 to $14.00 |
| 2013-10-14 | Reiterated Rating | Piper Jaffray | Overweight | $9.00 to $14.00 |
| 2013-10-02 | Boost Price Target | Raymond James | $15.00 | |
| 2013-04-15 | Reiterated | Canaccord Genuity | Buy | $14 to $18 |
| 2013-01-15 | Reiterated | Canaccord Genuity | Buy | $12 to $14 |
| 2016-06-17 | Initiated Coverage | Needham & Company LLC | Buy | $11.00 to $13.00 |
| 2016-06-08 | Reiterated Rating | Canaccord Genuity | Buy | |
| 2016-05-04 | Reiterated Rating | Canaccord Genuity | Buy | $8.00 |
| 2016-05-04 | Reiterated Rating | Needham & Company LLC | Buy | |
| 2016-02-26 | Lower Price Target | Raymond James | Outperform | $9.00 to $7.25 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In GNMK 15 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|---|
| OMNI PARTNERS LLP | 1.54M |
| BlackRock Fund Advisors | 1.49M |
| BlackRock Institutional Trust Company, N.A. | 1.18M |
| TIAA CREF INVESTMENT MANAGEMENT LLC | 0.18M |
| Concept Capital Markets, LLC | 0.17M |
| BlackRock Investment Management, LLC | 0.16M |
| TEACHERS ADVISORS INC | 0.15M |
| CATAPULT CAPITAL MANAGEMENT LLC | 55000 |
| MENTA CAPITAL LLC | 46543 |
| MANAGED ACCOUNT ADVISORS LLC | 37953 |
| BLACKROCK ADVISORS LLC | 24201 |
| BlackRock Group LTD | 22109 |
| Aperio Group, LLC | 18327 |
| Jump Trading, LLC | 17200 |
| LADENBURG THALMANN FINANCIAL SERVICES INC | 1000 |
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| MASSARANY HANY President and CEO | 1.69% (703835) | GNMK / |
| Gleeson Michael SVP, Sales | 0.89% (369422) | GNMK / |
| Mendel Scott Chief Financial Officer | 0.57% (239668) | GNMK / |
| Williams Jennifer Anne SVP Global Operations & HR | 0.53% (221544) | GNMK / |
| Kayyem Jon Faiz SVP, Research & Development | 0.47% (197622) | GNMK / |
| Stier Eric SVP & General Counsel | 0.47% (197173) | GNMK / |
| McNally James B. SVP, Marketing & Bus Dev | 0.36% (150811) | GNMK / |
| Mitchell Brian Andrew SVP, Operations | 0.34% (143890) | GNMK / |
| Chakravarty Ingo SVP, International | 0.33% (139229) | GNMK / |
| Hawkins Jeffrey Alan SVP, Marketing & Bus Dev | 0.27% (114619) | GNMK / |
| Fox James | 0.27% (111082) | BOTA / GNMK / |
| SLANSKY RICHARD B Chief Financial Officer | 0.19% (79534) | GNMK / ONCS / |
| Kagnoff Michael | 0.18% (74413) | GNMK / |
| FAULKNER DARYL | 0.17% (69419) | APPY / GNMK / |
| OBOYLE KEVIN C | 0.16% (65595) | DRTX / GNMK / SIEN / TRNX / ZLTQ / |
| Giles Lisa M. | 0.06% (23691) | DRTX / GNMK / |
| WORLAND STEPHEN T | 0.05% (20599) | GNMK / |
| GLEESON CHRISTOPHER M | 0.04% (17160) | GNMK / |
UM